Atrial Fibrillation
Read Time: 2 mins

114/Adverse LA remodelling is needed to decrease success rates in obese patients with AF: a single-centre retrospective study on RECURrence of Atrial Fibrillation following first time ablation (RECUR-AF)

Copy Link
Published Online: Oct 9th 2012 European Journal of Arrhythmia & Electrophysiology. 2022;8(Suppl. 1):abstr114
Authors: KZ Win (Presenting Author) – Queen Elizabeth Hospital Birmingham/University of Birmingham, Birmingham; MA Rauf – Queen Elizabeth Hospital Birmingham, Birmingham; I Shakeel – University of Birmingham, Birmingham; J De Bono – Queen Elizabeth Hospital Birmingham, Birmingham; M Lencioni – Queen Elizabeth Hospital Birmingham, Birmingham; H Marshall – Queen Elizabeth Hospital Birmingham, Birmingham; JN Townend – Queen Elizabeth Hospital Birmingham, Birmingham; R Steeds – Queen Elizabeth Hospital Birmingham, Birmingham; M Kalla – Queen Elizabeth Hospital Birmingham, Birmingham
Quick Links:
Article Information

Introduction: The outcome of atrial fibrillation (AF) ablation is suboptimal in overweight patients. This study reports the relationship of overweight patients and AF ablation outcome from a high-volume UK centre (>250 per year).

Methods: The study population consisted of 283 patients (mean age 62 ± 11 years, 61% male) who underwent their first-time AF ablation at Queen Elizabeth Hospital (QEH) Birmingham in 2018–2019. Recurrence of AF (AF >30 s, symptomatic recurrence) at 1 year (365 days) after 90-day blanking period was reviewed. Recurrence and no recurrence groups were compared according to body mass index (BMI), indexed left atrial (LA) volume and ablation methods.

Results: Mean BMI was 29.3 ± 5 kg/m2 and 111 (39%) patients were obese (BMI >30) at ablation despite risk factor (RF) modification advice at clinic. A total of 35 patients (12%) with morbid obesity (BMI >35 kg/m2) had higher prevalence of diabetes (1.7% in BMI <25 vs 22.9% in BMI >35; p=0.002), hypertension (18.3% in BMI <25 vs 57.1% in BMI >35; p<0.001) and sleep apnoea (nil in BMI <25 vs 20% in BMI >35; p<0.001). Overall, 25 patients (10%) had impaired left ventricular function (<50%) on echocardiography, and 109 patients (45%) had dilated indexed LA volume (>34 mL/m2) with mean 34.2 ± 12.5 mL/m2. In total, 15 patients (5%) had at least moderately severe valvular heart diseases. Single-procedure success rate in the cohort was 76% (74% pulmonary vein isolation only). The only predictor of outcome in our cohort between the recurrence vs no recurrence groups was indexed LA volume (37.1 ± 14.4 vs 33.3 ± 11.7 mL/m2; p=0.04). Higher BMI patients (BMI >30 and BMI >35) tended to have worse outcomes; however, results were not statistically significant (no recurrence 39.1% vs recurrence 39.7% in BMI >30 group, p=0.92; and no recurrence 9.8% vs recurrence 16.2% in BMI >35 group, p=0.14) (Table 1).

Conclusion: The success rate of first-time AF ablation at QEH was better than the published research data despite nearly 40% of our cohort consisting of obese patients with dilated LA. Obesity alone may not be a sufficient marker of poor outcome with ablation, but if associated with adverse LA remodelling, outcomes are poorer. Further mechanistic research is needed to optimise patient selection prior to catheter ablation. 

Further Resources

Share this Article
Related Content In Atrial Fibrillation
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72